Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Andrew Lazerow defends domestic and international clients in some of their most important antitrust litigation, including class actions and competitor disputes. In addition to his litigation practice, Mr. Lazerow regularly advises innovator pharmaceutical clients on various types of business issues, including potential settlements of Hatch-Waxman ANDA patent litigation, product life-cycle management, and REMS.

  • In re Rotavirus Vaccines Antitrust Litigation. Representing Merck in consolidated class action in Eastern District of Pennsylvania asserting antitrust challenges to Merck’s contracting practices that allegedly excluded competition from other pediatric vaccine manufacturers. 
  • Defended AstraZeneca in consolidated class action litigation involving allegations of unlawful settlements of Hatch-Waxman ANDA patent litigation. Achieved favorable trial outcome.
  • Defended Valeant Pharmaceuticals in consolidated class action litigation involving allegations of sham litigation. Achieved settlement after win on summary judgment.
  • Defending innovator pharmaceutical company in consolidated class action litigation involving allegations of unlawful settlements of Hatch-Waxman ANDA patent litigation.
  • Defending Citigroup in class actions involving antitrust and commodities fraud claims relating to alleged manipulation of financial benchmarks, including foreign currency exchange benchmarks and ISDAFIX®.
  • Defending JPMorgan in antitrust class actions and competitor actions involving alleged boycott of electronic exchanges for trading interest rate swaps.
  • Defended truck parts manufacturer against antitrust claims brought by a competitor.
  • Lead counsel to Dyadic International and current and former officers and directors in securities fraud litigation that settled favorably before extensive discovery or class certification briefing.
  • Represented Biovail Corporation and senior executives in a securities class action that settled before trial.
  • Represented manufacturer of optical disk drives in antitrust class actions alleging price fixing.

Pro Bono

  • Represents defendants in felony and misdemeanor trials in Washington, DC and Maryland courts.
  • Lead counsel for hearing-impaired prisoners in ADA claims against Michigan Department of Corrections.
  • Lead counsel for tenants in fair housing matters in Washington, DC. Achieved favorable settlements.

Previous Experience

  • Food and Drug Administration, Public Affairs Specialist